Key drug-pricing bill capping insulin costs faces hurdles in Congress
(The Hill) – Major drug-pricing legislation to cap the cost of insulin is in danger of slipping to the fall, where it risks getting lost amid fights over appropriations bills, abortion and a potential government shutdown.
